S-2720
S-2720 is a potent inhibitor of both immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) and HIV-1 replication. The binding sites of S-2720 and the nonnucleoside compounds overlap. The small pocket in the p66 subunit-BI-RG-587 (HY-10570) complex is most likely the target of S-2720. S-2720 is a quinoxaline derivative, which is promising for research of HIV-1 infection[1].
Product Specifications
UNSPSC
12352005
Target
HIV; Reverse Transcriptase
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/s-2720.html
Smiles
O=C(N1C2=CC(Cl)=CC=C2NC(C1(C)C)=S)OC(C)=C
Molecular Formula
C14H15ClN2O2S
Molecular Weight
310.80
References & Citations
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-117725/S-2720-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-117725/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[146739-86-8]
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MSH4 Antibody - N-terminal region : FITC (ARP41355_P050-FITC)
